Evaluation of Surgical Complications and DFS in Obese Rectal Cancer Patients
Evaluation of Intra- and Peri-operative Complications and Disease-free Survival in Rectal Cancer Patients Undergoing Oncological Resective Surgery and Concomitant Bariatric Surgery
1 other identifier
observational
90
1 country
1
Brief Summary
Obesity worsens treatment outcomes in rectal cancer patients: the local resective approach could in fact be more difficult in obese patients due to limited surgical visibility and it has also been reported that high visceral adiposity determines an increased risk of recurrence after chemoradiotherapy neoadjuvant. Bariatric surgery has proved to be the best choice for the treatment of morbid obesity and related comorbidities and in this context, the intragastric balloon (IGB) represents a strategy characterized by a low rate of complications and good results in terms of weight loss. Therefore, the need to be able to offer obese patients suffering from rectal cancer the possibility of a better recovery perspective, alongside radical oncological surgery and neoadjuvant treatments, also a bariatric surgery such as the positioning of an intragastric balloon.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 18, 2021
CompletedFirst Submitted
Initial submission to the registry
September 21, 2023
CompletedFirst Posted
Study publicly available on registry
September 28, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 18, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 18, 2025
CompletedSeptember 29, 2023
September 1, 2023
3 years
September 21, 2023
September 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Peri-operative complications
Peri-operative complications during rectal cancer surgery
Intra-operative complications and complications within 30 days from surgery
Secondary Outcomes (1)
Overall survival
3 years after surgery
Study Arms (1)
Obese Patients
Patients candidates for resective surgery for rectal cancer and also elegible for bariatric surgery
Interventions
BIB positioning in obese patients with rectal cancer elegible for neoadjuvant therapy
Eligibility Criteria
Obese patients, with locally advanced rectal cancer in clinical stage II-III, candidates for neoadjuvant therapy, who can underwent BIB positioning during neoadjuvant period to obtain weight loss before resective cancer surgery
You may qualify if:
- Patients with locally advanced rectal cancer in clinical stage II-III according to AJCC-UICC 2017 (candidates for neoadjuvant therapy)
- Patients suffering from I, II and III degree obesity at the same time
- Age between 18 and 70 years old
- BMI between 31 and 55 kg/m2
- Non-Smoking
- Candidates, according to AIOM guidelines, for rectal resection surgical procedures
- Candidates, according to SICOB guidelines, for an intragastric balloon placement procedure
You may not qualify if:
- Age ≤ 18 or ≥ 70 years
- BMI ≤ 30 or ≥ 59 Kg/m2
- Smoker
- Patients with non-locally advanced rectal cancer, not eligible for neoadjuvant therapy
- Histological positivity to Helicobacter pylori
- Presence of ulcerative lesions on EGD
- Previous bariatric surgery treatments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nunzio Velotti
Naples, 80131, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor of Surgery
Study Record Dates
First Submitted
September 21, 2023
First Posted
September 28, 2023
Study Start
February 18, 2021
Primary Completion
February 18, 2024
Study Completion
February 18, 2025
Last Updated
September 29, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share